Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Income Before Tax

$5.17B

TTM · Period ending: Jun 30, 2026 · USD

REGN Income Before Tax

Latest reported$5.17Bperiod endingJun 30, 2026

Latest reported$5.17Bperiod endingJun 30, 2026

REGN TTM Pre-Tax Income ($0.00 → $5.17B)

TTM income before tax

High-resolution chart · PNG

REGN income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Income Before Tax — Trailing twelve months (TTM) (USD)
Period ending	Income Before Tax (USD)
Jun 30, 2001	-44,762,000
Mar 31, 2001	-32,815,000
Dec 31, 2000	-29,851,000
Sep 30, 2000	-13,949,000
Jun 30, 2000	-15,698,000
Mar 31, 2000	-20,554,000
Dec 31, 1999	-22,100,000
Sep 30, 1999	-26,900,000
Jun 30, 1999	-23,300,000
Mar 31, 1999	-13,400,000
Dec 31, 1998	-8,400,000
Sep 30, 1998	-1,700,000
Jun 30, 1998	-1,400,000
Mar 31, 1998	-7,800,000
Dec 31, 1997	-9,800,000
Sep 30, 1997	-15,500,000
Jun 30, 1997	-18,900,000
Mar 31, 1997	-18,400,000
Dec 31, 1996	-20,100,000
Sep 30, 1996	-18,300,000
Jun 30, 1996	-16,300,000
Mar 31, 1996	-13,800,000
Dec 31, 1995	-8,400,000
Sep 30, 1995	-5,700,000
Jun 30, 1995	-3,300,000
Mar 31, 1995	-2,100,000
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	-9,100,000
Dec 31, 1993	-9,100,000
Sep 30, 1993	-9,100,000
Jun 30, 1993	-9,100,000
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	-2,100,000
Jun 30, 1992	-2,800,000
Mar 31, 1992	-3,300,000
Dec 31, 1991	-3,300,000
Sep 30, 1991	-1,200,000
Jun 30, 1991	-500,000
Mar 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.